Ronald A. Herman, Ph.D. College of Pharmacy, University of Iowa

Invited Lectures or Presentations (Select a button)

Peer-Reviewed Abstracts

  1. Parsai S, Herman RA, Johnson SJ. Systematic literature review of randomized controlled trials to evaluate the efficacy of medical marijuana for analgesia. Pharmacotherapy 2014;34(10):e287 [Poster #406] Presented at: ACCP 2014 Annual Meeting, Austin, TX, Oct. 13, 2014. 
  2. Saadah LM, Herman RA, Saadah SM. Complications following elective and non-elective cesarean section: a neural network analysis approach and prediction of post-surgical febrile morbidity and infections. Pharmacotherapy 2007;27(4):e16- [Poster #44] Presented at: ACCP 2007 Spring Practice and Research Forum, Memphis, TN; Apr. 24, 2007.  (Poster was a finalist in the Best Resident and Fellow category.)
  3. Saadah LM and Herman RA: Cefuroxime plus or minus metronidazole versus piperacillin and tazobactam in antimicrobial surgical prophylaxis for cesarean section: from drug utilization reviews to pharmacotherapy outcomes evaluations. ASHP Abstracts and Programs on CDROM 2006;[Poster SP185] Presented at: 41st Annual ASHP Midyear Clinical Meeting, Anaheim, CA, Dec. 4, 2006. 
  4. Herman RA: PDA NutriCalc a PDA program to facilitate nutritional assessment at the point of care. Am J Pharm Educ 2005; 60(3):S19 [Poster #S19] Presented at: American Association of Colleges of Pharmacy Annual Meeting, Cincinnati, OH, July 10, 2005. 
  5. Herman RA: Evaluation of student nutritional assessment recommendations with and without the use of a PDA program. Am J Pharm Educ 2005; 60(3):S78 [Poster #S78] Presented at: American Association of Colleges of Pharmacy Annual Meeting, Cincinatti, OH, July 10, 2005. 
  6. Goedken AM and Herman RA: Determination of the preferred time to send a quality assurance survey. [Presentation #1G3] Presented at: Midwest Pharmacy Residents Conference, Omaha, NE, May 6, 2005. 
  7. Herman RA, Cheng KJ, Lewis RW and Kealey GP: Comparison of the time below minimum inhibitory concentration (MIC) in burn patients and a control group following simulation of single daily dose aminoglycoside using measured multi-dose pharmacokinetic parameters. J Burn Care Rehabil 2001; 22(2):S97 [Presentation #101] Presented at: American Burn Association 33rd Annual Meeting, Boston, MA, Apr. 20, 2001. 
  8. Herman RA, Heinle J and Kealey GP: Evaluating the optimal oral dose of midazolam for conscious sedation. J Burn Care Rehabil 2001; 22(2):S80 [Presentation #69] Presented at: American Burn Association 33rd Annual Meeting, Boston, MA, Apr. 20, 2001. 
  9. Hirankarn S, Downs C, Street WN and Herman RA: Prediction of two ranges of cyclosporine level (subtherapeutic and toxic) using feature subset selection and artificial neural networks.. AAPS PharmSci 2000; 2(S1):[Poster #2588] Presented at: American Association of Pharmaceutical Scientists 2000 Annual Meeting, Indianapolis, IN, Oct. 31, 2000. 
  10. Hirankarn S, Herman RA and Cowles MK: Excellent predictive performance by hierarchiaical Bayesian approach using Gibbs sampler in population analysis. AAPS PharmSci 1999; 1(S1):[Poster/Podium #2001] Presented at: American Association of Pharmaceutical Scientists 1999 Annual Meeting, New Orleans, LA, Nov. 16, 1999. 
  11. Herman RA, Rosenquist MD and Chang P: The efficacy of combining 0.5% mafenide acetate suspension and nystatin as a broad spectrum topical burn wound antimicrobial. J Burn Care Rehabil 1999; 20(1):S233 [Poster #192] Presented at: American Burn Association 31st Annual Meeting, Orlando, FL, Mar. 25, 1999. 
  12. Chang P, Herman RA and Rosenquist MD: The efficacy of combining Neosporin GU irrigant and nystatin as a burn wound antimicrobial dressing. J Burn Care Rehabil 1999; 20(1):S232 [Poster #190] Presented at: American Burn Association 31st Annual Meeting, Orlando, FL, Mar. 25, 1999. 
  13. Rosenquist MD, Herman RA and Chang P: The efficacy and potency of combining nystatin with 0.1% silver sulfadiazine slurry as a broad spectrum topical antimicrobial. J Burn Care Rehabil 1999; 20(1):S231 [Poster #189] Presented at: American Burn Association 31st Annual Meeting, Orlando, FL, Mar. 25, 1999. 
  14. Hirankarn S, Herman RA, Noormoamed S, Stapleton JT, Shelton MJ and Hewitt RG: Comparison of an artificial neural network approach with five traditional methods for creatinine clearance prediction in human immunodeficiency virus infected individuals. AAPS PharmSci 1998; 1(1):S135 [Poster/Podium #2004] Presented at: American Association of Pharmaceutical Scientists 1998 Annual Meeting, San Francisco, CA, Nov. 17, 1998. 
  15. Hirankarn S, Phillips BG, Herman RA, Pesek CA, Narkiewicz K and Somers VK: Pharmacodynamic analysis by artificial neural network: mean arterial pressure prediction in obstructive sleep apnea. AAPS PharmSci 1998; 1(1):S136 [Poster/Podium #2007] Presented at: American Association of Pharmaceutical Scientists 1998 Annual Meeting, San Francisco, CA, Nov. 17, 1998. 
  16. Hirankarn S, Phillips BG, Herman RA, Pesek CA, Narkiewicz K and Somers VK: Merit of artificial neural network in population analysis. AAPS PharmSci 1998; 1(1):S520 [Poster #3561] Presented at: American Association of Pharmaceutical Scientists 1998 Annual Meeting, San Francisco, CA, Nov. 18, 1998. 
  17. Herman RA, Chang P, Rosenquist MD and Kealey GP: Stability and potency of 0.1% silver sulfadiazine slurry. J Burn Care Rehabil 1998; 19(1):S138 [Presentation #8] Presented at: American Burn Association 30th Annual Meeting, Chicago, IL, Mar. 19, 1998. 
  18. Chang P, Rosenquist MD, Herman RA and Kealey GP: Risk of contamination of topical antimicrobial mixtures with repeated use. J Burn Care Rehabil 1998; 19(1):S232 [Poster #195] Presented at: American Burn Association 30th Annual Meeting, Chicago, IL, Mar. 19, 1998. 
  19. Rosenquist MD, Herman RA, Chang P, Lewis RW and Kealey GP: Minimum inhibitory concentration of mafenide acetate against burn wound pathogens. J Burn Care Rehabil 1998; 19(1):S231 [Poster #192] Presented at: American Burn Association 30th Annual Meeting, Chicago, IL, Mar. 19, 1998. 
  20. Herman RA, Hirankarn S and Min DI: Gender comparison in prediction of cyclosporine dosage in liver transplant patients by artificial neural network. Pharm Research 1997; 14(11):S246 [Poster #2081] Presented at: American Association of Pharmaceutical Scientists 1997 Annual Meeting, Boston, MA, Nov. 4, 1997. 
  21. Herman RA: Neural network prediction of pharmacokinetic parameters from physicochemical characteristics. Pharm Research 1997; 14(11):S246 [Poster #2082] Presented at: American Association of Pharmaceutical Scientists 1997 Annual Meeting, Boston, MA, Nov. 4, 1997. 
  22. Chang P, Rosenquist MD, Herman RA, Lewis II RW and Kealey GP: Mafenide acetate slurry and neosporin mixture as a possible broad spectrum burn wound topical antimicrobial. J Burn Care Rehabil  1997; 18(1):S181 [Poster #222] Presented at: American Burn Association 29th Annual Meeting, New York, NY, Mar. 20, 1997. 
  23. Herman RA and Min DI: Artificial neural network prediction of cyclosporine dose in liver transplant patients. Clin Pharmacol Ther 1997; 61(2):157 [Poster #PI81] Presented at: 98th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, San Diego, CA, Mar. 5, 1997. 
  24. Herman RA, Kim LJ and Kealey GP: Effect of patient age, time since burn, and extent of burn injury on vancomycin pharmacokinetics. Pharm Research 1996; 13(9):S115 [Poster #CS3004] Presented at: American Association of Pharmaceutical Scientists 1996 Annual Meeting, Seattle, WA, Oct. 28, 1996. 
  25. Herman RA, Lewis RW and Kealey GP: Changes in vancomycin pharmacokinetics in burn patients. Proceedings of the American Burn Association 1996; 28:166 [Poster #245] Presented at: American Burn Association 28th Annual Meeting, Nashville, TN, Mar. 15, 1996. 
  26. Rosenquist MD, Herman RA, Lewis RW and Kealey GP: Stability and potency of 5% mafenide acetate suspension over time. Proceedings of the American Burn Association 1996; 28:173 [Poster #260] Presented at: American Burn Association 28th Annual Meeting, Nashville, TN, Mar. 15, 1996. 
  27. Rosenquist MD, Herman RA, Lewis RW and Kealey GP: Potency and stability of Neosporin as a burn wound antimicrobial over prolonged storage time. Proceedings of the American Burn Association 1996; 28:174 [Poster #261] Presented at: American Burn Association 28th Annual Meeting, Nashville, TN, Mar. 15, 1996. 
  28. Herman RA, Lewis II RW and Kealey GP: Rapidly achieving target vancomycin  concentrations in hypermetabolic burn patients. Crit Care Med 1995; 23(1 Suppl.):A68 [Poster #94] Presented at: Society of Critical Care Medicine 24th Educational and Scientific Symposium, San Francisco, CA, Feb. 1, 1995. 
  29. Herman RA, Lewis II RW and Kealey GP: Enhanced vancomycin dosing in burn patients using an improved method to estimate creatinine clearance. Can J Physiol Pharmacol 1994; 72(Suppl 1):298 [Poster #12.2.5] Presented at: 12th International Congress of Pharmacology, Montreal, Canada, July 27, 1994. 
  30. Herman RA, Veng-Pedersen P and Kealey GP: Application of a neural network to enhance prediction of creatinine clearance in patients with burns. Pharm Res 1994; 11(Suppl):S362 [Podium Presentation PPDM#8119] Presented at: American Association of Pharmaceutical Scientists 9th Annual Meeting, San Diego, CA, Nov. 7, 1994. 
  31. Herman RA and Kealey GP: Measured creatinine clearance compared to predicted creatinine clearance in burn patients. Pharm Res 1993; 10(Suppl):S103 [Poster CS#3009] Presented at: American Association of Pharmaceutical Scientists 9th Annual Meeting, Lake Buena Vista, FL, Nov. 17, 1993. 
  32. Herman RA and Kealey GP: Increased creatinine clearance in burn patients. Medicina Intensiva 1993; 17(Suppl 1):S90 [Presentation #327] Presented at: 6th World Congress on Intensive and Critical Care Medicine, Madrid, Spain, June 16, 1993. 
  33. Herman RA and Kealey GP: Altered elimination of vancomycin in burn patients. Medicina Intensiva 1993; 17(Suppl 1):S102 [Presentation #373] Presented at: 6th World Congress on Intensive and Critical Care Medicine, Madrid, Spain, June 15, 1993. 
  34. Herman RA and Veng-Pedersen P: Drug distribution kinetics related to physicochemical characteristics. Pharm Res 1993; 9(10):S329 [Poster PPDM#8292] Presented at: American Association of Pharmaceutical Scientists 7th Annual Meeting, San Antonio, TX, Nov. 18, 1992. 
  35. Herman RA, Veng-Pedersen P and Kealey GP: Clearance of morphine sulfate oral solution and sustained release (MS Contin®) in burn patients. Proceedings of the American Burn Association 1992; 24:55 [Presentation #55] Presented at: American Burn Association 24th Annual Meeting, Salt Lake City, UT, Apr. 2, 1992. 
  36. Herman RA, Veng-Pedersen P, Komorowski J and Kealey GP: Pharmacokinetics of morphine sulfate in burn patients. Clin Pharmacol Ther 1992; 51(2):133 [Poster #PI-48] Presented at: American Society for Clinical Pharmacology and Therapeutics 93rd Annual Meeting, Orlando, FL, Mar. 18, 1992. 
  37. Furst DE, Koehnke R, Herman RA, Hoffman J, Kohler J and Burmeister L: Methotrexate (MTX) kinetics may predict outcome in rheumatoid arthritis (RA) patients. Arthritis Rheum 1990; 33(Suppl):S61 [Poster #A119] Presented at: American College of Rheumatology 54th Annual Scientific Meeting, Seattle, WA, Oct. 29, 1990. 
  38. Kealey GP, Herman RA, Veng-Pedersen P, Heinle J and Lewis RW: Relative bioavailability of morphine-sulfate sustained-release (MS Contin) compared to morphine-sulfate oral solution in burn patients. Eur J Pharmacol  183(6):2377 [Presentation #2377] Presented at: 11th International Congress of Pharmacology, Amsterdam, Holland, July 6, 1990. 
  39. Herman RA, Kealey GP, Veng-Pedersen P, Heinle J and Lewis II RW: Relative bioavailability of morphine sulfate sustained release (MS Contin®) compared to morphine sulfate oral solution in burn patients. Proceedings of the American Burn Association 1990; 22:210 [Presentation #210] Presented at: American Burn Association 22nd Annual Meeting, Las Vegas, NV, Mar. 30, 1990. 
  40. Furst DE, Ericksen N, Koehnke R, Hoffman J, Clute L, Veng-Pedersen P and Herman RA: Effect of long-term low dose methotrexate (MTX) on MTX kinetics in rheumatoid arthritis (RA). Clin Pharmacol Ther 1990; 47(2):139 [Poster #PP-57] Presented at: American Society for Clinical Pharmacology and Therapeutics 91st Annual Meeting, San Francisco, CA, Mar. 21, 1990. 
  41. Furst DE, Herman RA, Koehnke R, Ericsksen N, Hash L, Porras A and Veng-Pedersen P: The effect of aspirin (ASA) or sulindac (SU) on methotrexate (MTX) clearance. Arthritis Rheum 1989; 32(Suppl):S60 [Poster #B65] Presented at: American College of Rheumatology 53rd Annual Scientific Meeting, Cincinnati, OH, June 15, 1989. 
  42. Furst DE, Herman RA, Hoffman J, Koehnke R and Veng-Pedersen P: Serum kinetics, synovial fluid levels and liver concentrations of MTX in 41 RA patients given methotrexate (MTX). Arthritis Rheum 1988; 31(Suppl):S116 [Poster #D83] Presented at: American College of Rheumatology 52nd Annual Scientific Meeting, Houston, TX, May 28, 1988. 

International (Visiting Professorships):

  1. Herman RA (Moderator): The Future of Pharmacy Education. Panel: Jolowsky C–Early Experiential Education in the Curriculum, Alkhateeb FM–Clinical Pharmacy Education in the U.S.; and Engle JP–Clinical Bedside Teaching: Teaching on the Run DUPHAT – Dubai International Pharmaceutical Technologies Conference & Exhibition, Dubai, UNITED ARAB EMIRATES, March 10, 2015; 2 Hr. program to 400 pharmacists and/or students.
  2. Herman RA: Workshop: The Use of Handheld/Tablet Resources to Access Drug Information. DUPHAT – Dubai International Pharmaceutical Technologies Conference & Exhibition, Dubai, UNITED ARAB EMIRATES, March 9, 2015; 1 Hr. workshop to 100 pharmacists and/or students.
  3. Herman RA: The Changing Role of Drug Information Centers with the Growth of Strong Clinical Pharmacy Services. DUPHAT – Dubai International Pharmaceutical Technologies Conference & Exhibition, Dubai, UNITED ARAB EMIRATES, March 8, 2015; 1 Hr. of lecture to 400 pharmacists and/or students.
  4. Herman RA: Drug Information Sources.  Medical Resident Training, CURE Hospital International, Kabul, AFGHANISTAN, May 17, 2006; 1 Hr. of lecture to 15 medical residents.
  5. Herman RA: The Internet as a Tool for Medical Professionals. Medical Resident Training, CURE Hospital International, Kabul, AFGHANISTAN, May 17, 2006; 2 Hrs. of hands on training to medical residents.
  6. Herman RA: Medical Management of the Burn Patient. Medical Resident Training, CURE Hospital International, Kabul, AFGHANISTAN, May 16, 2006; 1 Hr. of lecture to 25 medical residents and house staff.
  7. Herman RA: Drug Literature Evaluation and How to Operate a National Drug and Poison Information Center. Pharmacist Training, General Authority for Health Services, Abu Dhabi, UNITED ARAB EMIRATES, Sept. 10, 2005; 12 Hrs. of lecture and 48 hours of supervised training to 12 pharmacists.
  8. Herman RA: How to Use IDIS/Web.  Pharmacist Training, General Authority for Health Services, Abu Dhabi, UNITED ARAB EMIRATES, Sept. 10, 2005; 4 Hrs. of lecture to 65 pharmacists.
  9. Herman RA: How to Provide Drug Information Services and How to Use IDIS/Web. Standing Committee on Drugs, Botswana Department of Health and Social Welfare, Gaborone, BOTSWANA,  May 17 - 21, 2004; 5 days of personalized training for 3 pharmacists.
  10. Herman RA: Clinical Pharmacokinetics: Therapeutic Drug Monitoring. Advanced Pharmacokinetics Course II, Universidade de Lisboa, Lisbon, PORTUGAL,  February 16 & 17, 2000; 5 Hrs. of lecture.
  11. Herman RA: Model Independent Approach to Pharmacokinetic Data Analysis. Advanced Pharmacokinetics Course II, Universidade de Lisboa, Lisbon, PORTUGAL,  February 18 & 21, 2000; 5 Hrs. of lecture.

National

  1. Herman RA, THC, CBD and now Hemp Oil: Do they work? Are they safe? What's available legally?, Midwest Pharmacy Expo, Des Moines, IA, Feb. 8, 2020; 1 Hr ACPE# 0107-9999-20-028-L01-P.
  2. Herman RA. Honoring God through Pharmacy: A Panel Discussion on Leadership. C.E. Lecture, Christian Pharmacists Fellowship International Annual Meeting, Myrtle Beach, SC, May. 23, 2018; 1.25 Hr. ACPE# 0088-9999-19-079-L04-P.
  3. Herman RA. Student Pharmacist Outreach Opportunities, Student Retreat Talk, CPFI 2019 National Student Retreat, Myrtle Beach, SC, May. 23, 2018; 1 Hr.
  4. Herman RA. Pharmacist Mission Roles, Flat Rock, NC, Jun. 6 2015; 1.0 Hr. ACPE# 0088-9999-15-059-L04-P.
  5. Eckel F, Whaba W, Hames H, Allhands, KW, Lutz S, Sims L, and Herman RA. Honoring God Through Pharmacy: Sharing Life Experiences. C.E. Panel Discussion, Christian Pharmacists Fellowship International Annual Meeting, Springmaid Beach, SC, Jun. 13, 2014; 1.5 Hr. ACPE# 0088-9999-14-061-L04-P.
  6. Herman RA. Judicious Antibiotic Use in Developing Countries. C.E. Lecture, Christian Pharmacists Fellowship International Annual Meeting, Flat Rock, NC,  Jun. 8, 2013; 1 Hr.  ACPE# 0088-9999-13-083-L01-P.
  7. Herman RA. The pharmacist’s role on a short-term medical mission: A panel discussion. C.E. Lecture, Christian Pharmacists Fellowship International Annual Meeting, Flat Rock, NC,  Jun. 8, 2013; 1 Hr.  ACPE# 0088-9999-13-082-L04-P.
  8. Herman RA. Judicious Antibiotic Treatment in Developing Countries. C.E. Lecture, Global Missions Health Conference, Louisville, KY,  Nov. 9, 2012; 1 Hr.
  9. Herman RA. Drug Information Resources. C.E. Lecture, Alaska Pharmacists Association Annual Meeting, Anchorage, AK,  Feb. 19, 2012; 1.5 Hr.  ACPE# 0139-0000-12-116-L04-P.
  10. Herman RA. Scientific Evidence Concerning Medical Marijuana Use.  [Podium Report] Presented at: Alaska Board of Pharmacy Discussion on Medical Marijuana, Anchorage, AK; Feb. 17, 2012.
  11. Herman RA. Establishing Best Practices for Pharmacists on Short Term Mission Trips. C.E. Lecture, Christian Pharmacists Fellowship International Annual Meeting, Springmaid Beach, SC,  June 10, 2011; 1 Hr.  ACPE# 0088-9999-11-037-L04-P.
  12. Herman RA. Potential Dangers Associated with Treatment and Prophylaxis of Malaria. C.E. Lecture, Global Missions Health Conference, Louisville, KY,  Nov. 13, 2010; 1 Hr.
  13. Herman RA. Review of the WHO Guidelines for the Treatment of Malaria. C.E. Lecture, Global Missions Health Conference, Louisville, KY,  Nov. 13 & 14, 2009; 1 Hr. (delivered twice).
  14. Herman RA. POEMs: Patient Oriented Evidence that Matters. C.E. Lecture, Christian Pharmacists Fellowship International Annual Meeting, West Palm Beach, FL,  June 23, 2009; 1 Hr.  ACPE# 088-999-09-044-L04-P.
  15. Herman RA, Haack S, Johnson J, Soltis D, Seaba H. Pharmacists Making a Difference: Insight into Pharmacy Mission Trips. Panel Discussion, Iowa Pharmaceutical Association Educational Expo, Des Moines, IA,  Jan. 25, 2009; 1 Hr.
  16. Herman RA and Gray GC: Being Prepared for a Possible Pandemic Threat – Avian Influenza. C.E. Lecture, Global Missions Health Conference, Louisville, KY, Nov. 10, 2006; 1 Hr. ACPE# 143-999-06-106-L04.
  17. Herman RA: Drug Info at Your Fingertips: PDA's and Pocket Resources. C.E. Lecture, Christian Pharmacists Fellowship International Annual Meeting, SpringMaid Beach, SC, June 14, 2005; 1 Hr. ACPE # 088-999-05-005-L04.
  18. Herman RA: Moderator: Missionary Pharmacist Panel. C.E. Lecture, Christian Pharmacists Fellowship International Annual Meeting, SpringMaid Beach, SC, June 14, 2005; 1 Hr. ACPE # 088-999-05-006-L04.
  19. Herman RA: Drug Info at Your Fingertips: PDA's and Pocket Resources for Short Term Mission Trips. C.E. Lecture, Global Missions Health Conference, Louisville, KY,  November 12 & 13, 2004; 1 Hr.  ACPE# 143-000-04-63-L01.
  20. Herman RA: Panel: Missionary Pharmacy Experiences. C.E. Lecture, Christian Pharmacists Fellowship International Annual Meeting, Colorado Springs, CO, June 15, 2004; 1 Hr. ACPE # 088-999-04-009-L04.
  21. Herman RA: Medications To Go: A Mobile Pharmacy for Short Term Missions. C.E. Lecture, Global Missions Health Conference, Louisville, KY, Nov. 7, 2003; 1 Hr.  ACPE# 143-999-03-47-L01.
  22. Herman RA: Exploring PDA Usage: From Quiet Time to the Dispensing Counter to the Bedside. C.E. Lecture, Christian Pharmacists Fellowship International Regional Meeting, Vassar, KS, July 26, 2003; 3 Hr. ACPE # 088-999-03-028-L04.
  23. Herman RA: PDA Use by Pharmacy Practice Faculty and Concerns About Student Use/Misuse. AACP 2003 Annual Meeting, EBIR SIG Series of Instruction & Technology Related Topics, Minneapolis, MN, July 21, 2003; 2 Hr. ACPE # 038-999-03-041-L04.
  24. Herman RA: Antiparasitic Medications. C.E. Lecture, Christian Pharmacists Fellowship International Annual Meeting, SpringMaid Beach, SC, June 25, 2003; 1 Hr. ACPE # 088-999-03-014-L01.
  25. Herman RA and Herman B: Doing Medical Missions: A Pharmacist's Experience. C.E. Lecture, Christian Pharmacists Fellowship International Annual Meeting, SpringMaid Beach, SC, June 25, 2003; 1 Hr. ACPE # 088-999-03-013-L04.
  26. Herman RA: Antiparasitic Medications: Pharmacology, Dosing, Drug Interactions, and Adverse Effects. C.E. Lecture, Global Missions Health Conference, Louisville, KY, Nov. 2, 2002; 1 Hr.  AMA CE Category 1.
  27. Herman RA and Modrzejewski K: Clinical Research on the Mission Field. What's Appropriate and What's Not? C.E. Lecture, Global Missions Health Conference, Louisville, KY, Nov. 1, 2002; 1 Hr.  AMA CE Category 1.
  28. Herman RA: Pharmacotherapy of Bacterial & Viral Infections Encountered on Medical Missions. C.E. Lecture, Medical Missions Conference, Louisville, KY, Nov. 3, 2001; 1 Hr.  AMA CE Category 1.
  29. Herman RA: Pharmacotherapy of Tropical Diseases Encountered on Medical Missions. C.E. Lecture, Medical Missions Conference, Louisville, KY, Nov. 3, 2001; 1 Hr.  AMA CE Category 1.
  30. Herman RA: Pharmacotherapy of Drugs Commonly Used on Medical Missions. C.E. Lecture, Christian Pharmacists Fellowship International Annual Meeting, SpringMaid Beach, SC, June 19, 2001; 2 Hr. ACPE # 088-999-01-017-L01.
  31. Herman RA: The Role of the Pharmacist: Daily Responsibilities and Activities. C.E. Lecture, Medical Missions Conference, Louisville, KY, Nov. 18, 2000; 1 Hr.  AMA CE Category 1.
  32. Herman RA: Assessment of Nutritional Needs and Monitoring Nutritional Support for Hospital Based and Home Healthcare Patients. C.E. Lecture, Christian Pharmacists Fellowship International Regional Meeting, Vassar, KS, July 22, 2000; 3 Hr. ACPE # 088-999-00-019-L04.
  33. Herman RA: The Plague of Boils: Pharmacotherapy of Topical Skin Infections in Biblical Times and Now. C.E. Lecture, Christian Pharmacists Fellowship International Annual Meeting, SpringMaid Beach, SC, June 7, 2000; 1 Hr. ACPE # 088-000-00-007-L01.
  34. Herman RA: The Plague of Boils: Pharmacotherapy of Topical Skin Infections in Biblical Times and Now. C.E. Lecture, Christian Pharmacists Fellowship International Regional Meeting, Vassar, KS, Aug. 21, 1999; 3 Hr. ACPE #088-000-99-018-L04.
  35. Herman RA: The Y2K Problem and the Pharmacist. C.E. Lecture, 12th Annual Christian Pharmacists Fellowship International Annual Meeting, Greenville, SC, July 23, 1999; 1 Hr. ACPE # 088-000-99-013-L04.
  36. Herman RA: Pharmacotherapy:  Care of the Burn Patient. C.E. Lecture, 11th Annual Christian Pharmacists Fellowship International Annual Meeting, Wilmore, KY, July 23, 1998; 3 Hr. ACPE # 088-000-98-002-L01.
  37. Herman RA: The Pharmacist in Medical Relief Situations: Developing Cross-Cultural Relationships in Short-term Missions. C.E. Lecture, 10th Annual Christian Pharmacists Fellowship International Annual Meeting, Springmaid Beach, SC, Aug. 18, 1997; 1 Hr. ACPE # 088-000-97-011-L04.

Local

  1. Herman RA: Updates on Medical Cannabis Use in Iowa . Hall-Perrine Cancer Center 30th Annual Cancer Care Update, Cedar Rapids, IA Oct.10, 2019; 1 Hr.
  2. Herman RA: Updates on Medical Cannabis Use in Iowa . 2019 Fall Cancer Update for Dental Health Professionals, Cedar Rapids, IA Oct. 2nd and repeated the 4th, 2019; 1 Hr.
  3. Herman RA: Updates on Medical Cannabis Use in Iowa . 2019 Scofield Advanced Oncology Nursing Conference, Coralville, IA Apr. 2, 2019; 1 Hr.
  4. Herman RA: Medical Cannabis – Cannabis Dispensaries Open December 1st – What’s Our Role? University of Iowa Issues in Transplantation Conference, Iowa City, IA Dec. 18, 2018; 1 Hr.
  5. Herman RA: Current Iowa Medical Cannabis Regulations. Blackhawk-Bremer County Pharmacists Association, Cedar Falls, IA Nov. 29, 2018; 1 Hr.
  6. Herman RA: Current Status of Medical Cannabis Legislation in Iowa. 14th Annual Iowa Lakes Health Conference, Lake Okoboji, IA Jun. 7, 2018; 1.5 Hr.
  7. Herman RA: Current Iowa Medical Cannabis Regulations. Northeast Iowa Medical Education Foundation, Cedar Falls, IA May 2, 2018; 1 Hr.
  8. Herman RA: Medical Cannabis – The Science & Current Legal Status. University of Iowa Cancer Center Grand Rounds, Grand Rounds, Iowa City, IA Jan. 26, 2018; 1 Hr.
  9. Herman RA: Medical Cannabidiol – Dosing Considerations. Iowa Medical Cannabidiol Advisory Board, Board Meeting, Ankeny, IA Jan. 19, 2018; 1 Hr.
  10. Herman RA: Medical Cannabis – Weighing the Benefits & the Risks. Iowa Society for Therapeutic Radiation Oncology, Annual Meeting, Iowa City, IA Oct. 14, 2017; 1 Hr.
  11. Herman RA: Current Status of the Iowa Medical Cannabis Program. Johnson County Pharmacists Association, Iowa City, IA Aug. 30, 2018; C,E. 0107-9999-18-233-L01-P; 1 Hr.
  12. Herman RA: Establishing Best Practices for Pharmacists on Short Term Mission Trips. Online Lecture, University of the Incarnate Word School of Pharmacy, San Antonio, TX, Oct. 11, 2017; 1 Hr.
  13. Herman RA: An Introduction to Applied Pharmacokinetics. Lecture to Physician Assistant Students, St. Ambrose University, Davenport, IA, Jan. 31, 2017; 3 Hr.
  14. Herman RA: Medical Cannabis – Weighing the Benefits & the Risks. Iowa Developmental Disabilities Nursing Assoc., Fall Conference, Des Moines, IA Sept. 16, 2016.
  15. Herman RA: Reflections on Adding Oil to the Fire – Uses of Medical Marijuana for Pediatric Epilepsy. Pediatric Grand Rounds, University of Iowa Healthcare, Iowa City, IA, Feb. 5, 2016; 1 Hr.
  16. Herman RA: An Introduction to Applied Pharmacokinetics. Lecture to Physician Assistant Students, St. Ambrose University, Davenport, IA, Jan. 19, 2016; 3 Hr.
  17. Herman RA: Malaria Treatment and Prophylaxis. C.E. Lecture, GHO Trip, Ethiopia, Oct. 27, 2015; 1 Hr.
  18. Herman RA. Update on Tropical Medicine. C.E. Lecture, Christian Pharmacists Fellowship International Annual Meeting, Myrtle Beach, SC, Jun. 11 2016; 1.0 Hr. ACPE# 0088-9999-16-065-L04-P.
  19. Herman RA: Establishing Best Practices for Pharmacists on Short Term Mission Trips. Online Lecture, University of the Incarnate Word School of Pharmacy, San Antonio, TX, Sept. 30, 2015; 1 Hr.
  20. Herman RA: Establishing Best Practices for Pharmacists on Short Term Mission Trips. Online Lecture, University of the Incarnate Word School of Pharmacy, San Antonio, TX, Sept. 3, 2014; 1 Hr.
  21. Herman RA: Establishing Best Practices for Pharmacists on Short Term Mission Trips. Online Lecture, University of the Incarnate Word School of Pharmacy, San Antonio, TX, Sept. 11, 2013; 1 Hr.
  22. Herman RA: A Systematic Approach to Responding to Drug Information Questions. Online Lecture, Coram Healthcare Pharmacy Residents, Jackson, FL, Aug. 19, 2013; 1 Hr.
  23. Herman RA: Establishing Best Practices for Pharmacists on Short Term Mission Trips. Online Lecture, University of the Incarnate Word School of Pharmacy, San Antonio, TX,  Feb. 2, 2012 and Sept. 19, 2012; 1 Hr.
  24. Herman RA: Medical Marijuana, Evaluation of the Evidence, Community Gathering, Melrose Meadows, Iowa City, IA, Jul. 12, 2011; 0.5 Hour.
  25. Herman RA: Medical Marijuana, Evaluation of the Evidence, Serotoma Club Luncheon, University Athletic Club, Iowa City, IA, Oct. 21, 2010; 0.5 Hour.
  26. Herman RA: Medical Marijuana, Evaluation of the Evidence, Oaknoll Retirement Center, Iowa City, IA, July 1, 2010; 0.5 Hour.
  27. Herman RA: Medical Marijuana, Evaluation of the Evidence, Marshalltown Lions Club Luncheon, Marshalltown, IA, Apr. 4, 2010; 0.5 Hour.
  28. Herman RA and Schmidt N: Mosquitoes and Malaria, Hawkeye Area Boy Scouts, Wickham School, Iowa City, IA, Mar. 25, 2010; 0.5 Hour.
  29. Herman RA, Hanson K, Marinez Narhi R. Serving Diverse Communities: Practitioner Panel. Humans Rights Week Diversity Committee Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Jan. 30, 2008.
  30. Herman RA: Disaster Preparedness. 46:006 Dean's Honors Seminar II, University of Iowa College of Pharmacy, Iowa City, IA, Oct. 6, 2006; 1 Hour.
  31. Herman RA: Evaluation of Student Nutritional Assessment Recommendations With and Without the Use of a PDA Program. Faculty Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Apr. 13, 2005.
  32. Herman RA: Volunteerism. 46:102 Dean's Honors Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Nov. 13, 2003.
  33. Herman RA: PDA's for Faculty: What to Buy, How to Use and Concerns About Student Use/Misuse. Faculty Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Mar. 23, 2003; 1 Hr. ACPE# 020-000-03-011-L04.
  34. Herman RA: Drug Information Resources Offered by DDIS: Where To Find Them and How To Use Them. ICN Broadcast to Pharmacy Preceptors, University of Iowa College of Pharmacy, Iowa City, IA, Nov. 20, 2002; 2 Hr. ACPE# 020-000-02-035-L04.
  35. Herman RA: Report on the Development of an Electronic Clinical Pharmacokinetic Drug Dosing Program for Handheld Devices. Innovations in Instructional Computing Conference, University of Iowa Lindquist Center, Iowa City, IA, Sept. 12, 2002.
  36. Herman RA: Drug Information Resources Offered by DDIS: Where to Find Them and How to Use Them. Faculty Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Apr. 17, 2002.
  37. Herman RA: Artificial Neural Networks: A New Tool for Pharmacokinetics. Faculty Seminar, University of Mississippi College of Pharmacy, Oxford, MS, Mar. 30, 2001.
  38. Herman RA: Altered Elimination of Antibiotics in Burn Patients. Faculty Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Oct. 10, 2000; 1 Hr. ACPE # 020-000-00-042-L01.
  39. Herman RA: Stability and Efficacy of Three Topical Antimicrobial Solutions. Clinical Pharmacy Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Sept. 21, 2000.
  40. Herman RA: Use of Midazolam Syrup in Conscious Sedation. Nursing Inservice Lecture, Burn Treatment Center, University of Iowa Hospitals & Clinics, Iowa City, IA,  Dec. 14 & 15, 1998.
  41. Herman RA: Evaluation of a Neural Network to Enhance Prediction of Creatinine Clearance in Patients with Burns. Clinical Pharmacy Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Sept. 9, 1998.
  42. Herman RA: Stability and Efficacy of Three Topical Antimicrobial Solutions. Clinical Pharmacy Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Mar. 31, 1998.
  43. Herman RA: Neural Network Prediction of Pharmacokinetic Parameters from Physicochemical Characteristics. Clinical Pharmacy Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Nov. 20, 1997.
  44. Herman RA: Stability of Neosporin Solution and Mafenide Acetate Slurry for the Topical Treatment of Thermal Injuries. Clinical Pharmacy Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Apr. 30, 1997.
  45. Herman RA: Current Trends in Pharmacokinetic Modeling. Biotransport Class Presentation, University of Iowa College of Engineering, Iowa City, IA, Dec. 6, 1996.
  46. Herman RA: Effect of Patient Age, Time Since Burn, and Extent of Burn Injury on Vancomycin Pharmacokinetics. Clinical Pharmacy Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Oct. 16, 1996.
  47. Kim LJ and .Herman RA: Medicine Safety. 4th Annual Health and Safety Fair, University of Iowa Field House, Iowa City, IA, May 14, 1996.
  48. Herman RA: Population Pharmacokinetics. Clinical Pharmacy Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Nov. 13, 1995.
  49. Herman RA: Medicine Safety. Health and Safety Fair, University of Iowa Field House, Iowa City, IA, May 16, 1995.
  50. Herman RA: Neural Networks as a Research Tool in Pharmacokinetics. Honors Seminar, University of Iowa College of Pharmacy, Iowa City, IA, May 2, 1995.
  51. Herman RA: Application of Neural Networks to Clinical Pharmacokinetics/ Pharmacodynamics. Pharmacy Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Feb. 15, 1995.
  52. Herman RA: An Introduction to Neural Networks in Clinical Pharmacokinetics. Pharmacy Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Nov. 17, 1993.
  53. Herman RA: Age Related Pharmacokinetic Changes. Clinical Skills Course, University of Iowa Hospitals & Clinics, Iowa City, IA, Oct. 14, 1992.
  54. Herman RA: Basic Pharmacokinetics. Clinical Skills Course, University of Iowa Hospitals & Clinics, Iowa City, IA, Sept. 23, 1992.
  55. Herman RA: Pharmacokinetics of Continuous Release Morphine in Burn Patients. Pharmaceutics Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Feb. 17, 1992.
  56. Herman RA: Drug Distribution Kinetics Related to Physicochemical Characteristics. Pharmaceutics Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Mar. 31, 1989.
  57. Herman RA: Curve Fitting with a Sum of Exponentials. Pharmaceutics Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Sept. 25, 1987.
  58. Herman RA: Pharmacokinetics of Low Dose Methotrexate in Rheumatoid Arthritis Patients. Pharmaceutics Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Nov. 14, 1986.
  59. Herman RA: Quantitative Relationships Between Physicochemical Properties of Drugs and Their Pharmacokinetics. Pharmaceutics Research Seminar, University of Iowa College of Pharmacy, Iowa City, IA, Sept. 6, 1985.